<table border="1"><tr><th>Name UICPA</th><td><ul><li>acid (2&#x27;&#x27;S&#x27;&#x27;,&#x27;&#x27;5R&#x27;&#x27;,6&#x27;&#x27;R&#x27;&#x27;)-3,3-dimethyl-7-oxo-6-[[(2&#x27;&#x27;R&#x27;&#x27;)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic</li></ul></td></tr><tr><th>N | o | CAS</th><td><ul><li>37091-66-0</li></ul></td></tr><tr><th>N | o | ECHA</th><td><ul><li>100.048.483</li></ul></td></tr><tr><th>N | o | EC</th><td><ul><li>253-348-2</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li>J01 | CA09</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB01061</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>6479523</li></ul></td></tr><tr><th>ChEBI</th><td><ul><li>2956</li></ul></td></tr><tr><th>SMILES</th><td><ul><li>CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C | PubChem |, | 3D view</li></ul></td></tr><tr><th>InChI</th><td><ul><li>InChI | 3D view | InChI=1S/C20H23N5O6S/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30/h3-7,11-13,16H.8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29)/t11-,12-,13+,16-/m1/s1 | InChIKey | JTWOMNBEOCYFNV-NFFDBGFSA-N</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C | 20 | H | 23 | N | 5 | O | 6 | S</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>461.492 ± 0.025 g/mol | C 52.05%, H 5.02%, N 15.18%, O 20.8 %, S 6.95%,</li></ul></td></tr><tr><th>Solubility</th><td><ul><li>water | 0.233 | g | · l | -1 |, sodium salt | 50 | g | · | l | -1</li></ul></td></tr><tr><th>LogP</th><td><ul><li>(water/octanol) 0.2</li></ul></td></tr><tr><th>Protein binding</th><td><ul><li>20 to 46%</li></ul></td></tr><tr><th>Half-life of | elim.</th><td><ul><li>1.3 to 1.5 hours</li></ul></td></tr></table>